1_PARAGRAPHS

['   \n\nFigure S1. Median relative abundance of bacterial taxa at the phylum level in infant gut microbiota at 3-4 months, by infant sex. \n\n \n\n \n\n \n\n2 \n\nAll infants (N=1021)61822186212218ActinobacteriaBacteroidetesFirmicutesProteobacteriaVerrucomicrobia692419Female infants (N=476)Male infants (N=545)\x0cTable S1. Median relative abundance of bacterial phyla, and microbial richness and diversity in infant gut microbiota at 3-4 months, according to \n\nmaternal prenatal asthma and infant sex.  \n\n \nAlpha metrics \nChao1 richness \nestimator \nShannon diversity \nindex \nSimpson diversity \nindex \n\nBacterial phyla \nActinobacteria \n\nBacteroidetes \n\nFirmicutes \n\nProteobacteria \n\nVerrucomicrobia \n\nCrude p \n \n\nNo Asthma \n(n=934) \n \n342.3 \n(285.4-403.8) \n3.1  \n(2.6-3.6) \n0.77  \n(0.66-0.83) \n \n5.7  \n(1.4-15.3) \n17.7  \n(0.1-60.3) \n23.4  \n(9.0-44.8) \n18.5  \n(7.9-40.4) \n0.002  \n(0.0003-0.01) \n\n0.90 \n\nAll infants \nAsthma \n(n=87) \n \n365.5  \n(300.6-400.3)  0.19 \n3.1  \n(2.5-3.6) \n0.54  \n(0.42-0.63) \n \n4.7  \n(1.4-15.0) \n24.1  \n(0.1-70.4) \n18.0  \n(7.5-41.2) \n15.4  \n(8.2-35.1) \n0.002 \n(0.0004-0.01)  0.87 \n\n0.95 \n \n\n0.31 \n\n0.97 \n\n0.21 \n\n0.20 \n\nNo Asthma \n(n=430) \n \n349.4  \n(289.6-409.0) \n3.1  \n(2.7-3.6) \n0.78  \n(0.67-0.84) \n \n5.7  \n(1.6-14.7) \n19.1  \n(0.1-60.4) \n23.1  \n(9.7-47.0) \n18.2  \n(8.4-40.1) \n0.003 \n(0.0004-0.006) \n\nFemale infants \nAsthma \n(n=46) \n \n371.8  \n(304.4-411.3) \n3.2  \n(2.4-3.4) \n0.76  \n(0.65-0.84) \n \n5.1  \n(1.7-15.0) \n34.8  \n(0.2-72.9) \n16.5  \n(5.6-31.3) \n13.8  \n(8.2-32.6) \n0.002  \n(0.0-0.008) \n\nNo Asthma \n(n=504) \n \n335.7 \n(283.7-395.6) \n3.1  \n(2.6-3.5) \n0.76  \n(0.65-0.83) \n \n5.7  \n(1.2-17.3) \n12.0  \n(0.1-60.2) \n23.5  \n(8.9-43.5) \n19.3  \n(7.7-40.4) \n0.002  \n(0.0003-0.006) \n\nMale infants \nAsthma \n(n=41) \n \n362.5  \n(298.8-396.1) \n3.0  \n(2.7-3.6) \n0.75  \n(0.70-0.85) \n \n3.9  \n(1.4-14.6) \n0.8  \n(0.1-69.4) \n27.4  \n(10.6-52.6) \n16.9  \n(7.0-35.1) \n0.002  \n(0.0005-0.006) \n\nCrude p \n \n\n0.25 \n\n0.61 \n\n0.51 \n \n\n0.71 \n\n0.99 \n\n0.40 \n\n0.43 \n\n0.88 \n\nCrude p \n \n\n0.53 \n\n0.70 \n\n0.57 \n \n\n0.74 \n\n0.08 \n\n0.03 \n\n0.34 \n\n0.95 \n\nResults are presented as median and inter quartile range in brackets. Comparisons were performed by Wilcoxon rank sum test. FDR was used to adjust p values for \n\nmultiple testing, and p values <FDR p are indicated with ‘*’. P values <0.05 are indicated in boldface type. \n\n \n\n \n\n3 \n\n\x0cNo Asthma \n(n=186) \n7.0 (2.0-19.0) \n0.03 (0.005-0.1) \n0.03 (0.003-0.1) \n6.6 (1.8-18.4) \n6.6 (1.8-18.4) \n33.2 (0.8-63.2) \n27.1 (0.3-60.8) \n27.1 (0.3-60.8) \n\nFemale infants \nRestricted to vaginally-delivered, breastfed infants, \nnot exposed to maternal antibiotics during birth \nAsthma \n(n=21) \n6.4 (2.5-13.5) \n0.01 (0.003-0.03) \n0.007 (0.001-0.02) \n6.4 (1.7-13.4) \n6.4 (1.7-13.4) \n65.3 (28.1-78.5) \n52.3 (28.1-76.8) \n52.3 (28.1-76.8) \n0.007 (0.002-2.4) \n9.3 (3.4-17.1) \n0.003 (0.0003-0.03) \n0.003 (0.0003-0.03) \n0.2 (0.03-0.7) \n0.005 (0.002-0.5) \n0.7 (0.3-4.5) \n0.001 (0.0-0.02) \n0.001 (0.0003-0.005) \n0.06 (0.004-1.9) \n0.0005 (0.0-0.05) \n1.6 (0.5-4.3) \n\n16.0 (7.2-33.9) \n0.003 (0.0002-0.07) \n0.003 (0.0002-0.07) \n0.2 (0.02-2.2) \n0.02 (0.004-0.7) \n1.8 (0.03-7.9) \n0.0006 (0.0-0.003) \n0.0003 (0.0-0.002) \n0.03 (0.003-0.7) \n0.0006 (0.0-0.04) \n3.2 (0.4-12.2) \n\nCrude \np \n- \n0.07 \n0.08 \n- \n- \n0.01* \n0.02* \n0.02* \n- \n0.05 \n- \n- \n- \n- \n- \n- \n0.03* \n- \n- \n- \n\nMale infants \nRestricted to vaginally-delivered, breastfed infants, not \nexposed to maternal antibiotics during birth \nAsthma \n(n=11) \n12.7 (2.0-26.6) \n0.02 (0.002-0.09) \n0.009 (0.002-0.03) \n12.2 (1.8-26.6) \n12.2 (1.8-26.6) \n50.3 (0.2-78.8) \n22.6 (0.1-58.7) \n22.6 (0.1-58.7) \n0.02 (0.002-13.7) \n21.5 (6.8-34.9) \n0.0005 (0.0-0.002) \n0.0005 (0.0-0.002) \n0.4 (0.02-2.5) \n0.008 (0.002-0.4) \n2.1 (0.3-15.6) \n0.001 (0.0-0.1) \n0.0 (0.0-0.002) \n0.03 (0.003-1.1) \n0.0003 (0.0-0.01) \n2.6 (0.4-10.9) \n\nNo Asthma \n(n=208) \n6.8 (2.3-18.5) \n0.01 (0.001-0.06) \n0.008 (0.001-0.04) \n6.2 (2.0-17.8) \n6.2 (2.0-17.8) \n40.2 (0.5-67.8) \n35.6 (0.4-60.8) \n35.6 (0.4-60.8) \n0.005 (0.001-0.7) \n14.6 (5.9-30.6) \n0.003 (0.0-0.05) \n0.003 (0.0-0.05) \n0.07 (0.01-0.8) \n0.006 (0.002-0.1) \n1.1 (0.03-5.8) \n0.0007 (0.0-0.003) \n0.0004 (0.0-0.002) \n0.04 (0.002-0.7) \n0.0009 (0.0-0.05) \n2.3 (0.4-12.7) \n\nCrude \np \n- \n- \n- \n- \n- \n- \n- \n- \n- \n- \n0.06 \n0.06 \n- \n- \n- \n- \n- \n- \n- \n- \n\n4 \n\nActinomycetaceae \nActinomyces \nBifidobacteriaceae \nBifidobacterium \n\nBacteroidetes \n\nacterial taxa \nActinobacteria \n\n  B\n\nFirmicutes \n\n‡Lactobacillaceae \n‡Lactobacillus \nClostridiaceae \nClostridium \nLachnospiraceae \nBlautia \nDorea \nRuminococcaceae \nRuminococcus \nVeillonellaceae \n\n \n\nBacteroidaceae \nBacteroides \nPorphyromonadaceae  0.006 (0.002-0.2) \n\nTable S2. Median relative abundance of bacterial taxa in infant gut microbiota at 3-4 months, according to maternal prenatal asthma \n\nand infant sex. Comparisons were restricted to vaginally-delivered, breastfed infants not exposed to maternal antibiotics during birth. \n\n\x0cDialister \nMegasphaera \nVeillonella \nProteobacteria \n\n0.0007 (0.0-0.006) \n0.001 (0.0-0.006) \n1.9 (0.2-11.1) \n19.4 (10.0-35.7) \n17.8 (7.0-34.2) \n0.001 (0.0004-0.005)  0.002 (0.0-0.006) \nVerrucomicrobiaceae  0.001 (0.0004-0.005)  0.002 (0.0-0.006) \n0.001 (0.0004-0.005)  0.002 (0.0-0.006) \nAkkermansia \n\n- \n- \n- \n- \n- \n- \n- \n- \nResults are presented as median and inter quartile range in brackets. Comparisons were performed by Wilcoxon rank sum test. FDR was used to adjust p values \n\n0.0004 (0.0-0.003) \n0.0009 (0.0-0.005) \n1.5 (0.2-7.4) \n16.2 (7.4-41.2) \n15.1 (5.9-39.6) \n0.002 (0.0002-0.006)  0.0007 (0.0-0.003) \n0.002 (0.0002-0.006)  0.0007 (0.0-0.003) \n0.002 (0.0002-0.006)  0.0007 (0.0-0.003) \n\n0.0003 (0.0-0.02) \n0.0005 (0.0003-0.006) \n0.5 (0.1-2.6) \n13.8 (10.8-28.2) \n13.8 (6.8-27.9) \n\n0.001 (0.0-0.005) \n0.0006 (0.0-0.001) \n1.3 (0.1-4.2) \n9.8 (8.2-22.6) \n9.7 (5.5-16.5) \n\n- \n0.11 \n- \n0.04 \n0.03* \n- \n- \n- \n\nEnterobacteriaceae \n\nVerrucomicrobia \n\nfor multiple testing, and p values <FDR p are indicated with ‘*’. P values <0.05 are indicated in boldface type. \n\n‡Comparison of Lactobacillaceae family was the primary hypothesis. \n\n \n\n5 \n\n\x0cTable S3. Median relative abundance of bacterial taxa at phylum, family and genus level in fecal microbiota at 3-4 months according \n\nto maternal asthma during pregnancy, restricted to Caucasian mothers and stratified by prenatal maternal allergy status. \n\nMaternal allergies during pregnancy \nRestricted to Caucasian mothers \n\nBacterial taxa \nActinobacteria \n\nActinomycetaceae \nActinomyces \nBifidobacteriaceae \nBifidobacterium \n\nBacteroidetes \n\nNo Asthma \n(n=429) \n6.1 (1.5-16.9) \n0.03 (0.005-0.1) \n0.02 (0.004-0.09) \n5.4 (1.3-16.1) \n5.4 (1.3-16.1) \n13.3 (0.1-57.6) \n8.4 (0.07-53.0) \n8.4 (0.07-53.0) \n\nFirmicutes \n\nBacteroidaceae \nBacteroides \nPorphyromonadaceae  0.005 (0.002-0.2) \n22.2 (10.1-44.7) \n0.002 (0.0-0.05) \n0.002 (0.0-0.05) \n0.3 (0.03-2.5) \n0.02 (0.003-0.5) \n2.9 (0.1-9.8) \n0.002 (0.0-0.07) \n0.0004 (0.0-0.003) \n0.1 (0.006-1.6) \n0.001 (0.0-0.07) \n4.0 (0.7-15.4) \n0.0006 (0.0-0.004) \n0.001 (0.0-0.007) \n\n‡Lactobacillaceae \n‡Lactobacillus \nClostridiaceae \nClostridium \nLachnospiraceae \nBlautia \nDorea \nRuminococcaceae \nRuminococcus \nVeillonellaceae \nDialister \nMegasphaera \n\n \n\nCrude \np \n- \n\nNo maternal allergies during pregnancy \nRestricted to Caucasian mothers \nAsthma \n(n=10) \n4.6 (0.7-36.1) \n0.003 (0.0008-0.03)  <0.04 \n0.003 (0.0008-0.03)  <0.04 \n4.5 (1.1-21.7) \n4.5 (1.1-21.7) \n0.4 (0.09-34.2) \n0.1 (0.06-34.2) \n0.1 (0.06-34.2) \n0.006 (0.003-0.02) \n26.8 (3.2-75.5) \n0.0009 (0.0-0.003) \n0.0009 (0.0-0.003) \n0.3 (0.09-0.8) \n0.007 (0.004-0.3) \n3.9 (0.2-32.0) \n0.02 (0.0-0.1) \n0.002 (0.0-0.03) \n0.1 (0.005-4.2) \n0.02 (0.0005-0.06) \n0.7 (0.2-4.3) \n0.0001 (0.0-0.01) \n0.002 (0.0-0.004) \n\nNo Asthma \n(n=278) \n5.5 (1.5-15.1) \n0.03 (0.004-0.1) \n0.03 (0.004-0.1) \n4.9 (1.1-13.8) \n4.9 (1.1-13.8) \n24.3 (0.1-68.1) \n18.0 (0.09-61.7) \n18.0 (0.09-61.7) \n0.004 (0.002-0.09) \n24.4 (7.8-47.6) \n0.003 (0.0-0.05) \n0.003 (0.0-0.05) \n0.5 (0.06-2.5) \n0.03 (0.004-0.8) \n3.1 (0.05-10.8) \n0.001 (0.0-0.03) \n0.0005 (0.0-0.003) \n0.09 (0.003-1.7) \n0.0007 (0.0-0.06) \n4.8 (0.8-16.8) \n0.0004 (0.0-0.003) \n0.0008 (0.0-0.006) \n\n- \n- \n- \n- \n- \n- \n- \n- \n- \n- \n- \n- \n- \n- \n- \n- \n- \n- \n- \n\nCrude \np \n- \n- \n- \n- \n- \n0.08 \n0.09 \n0.09 \n- \n- \n\nAsthma \n(n=64) \n4.7 (1.4-18.6) \n0.03 (0.008-0.09) \n0.02 (0.005-0.09) \n4.3 (1.3-15.0) \n4.3 (1.3-15.0) \n32.6 (0.2-72.4) \n28.0 (0.1-67.2) \n28.0 (0.1-67.2) \n0.006 (0.002-1.0) \n17.2 (7.8-35.8) \n0.0005 (0.0-0.009)  0.03* \n0.0005 (0.0-0.009)  0.03* \n0.2 (0.02-2.0) \n0.01 (0.003-0.4) \n 2.4 (0.2-9.6) \n0.001 (0.0-0.04) \n0.0004 (0.0-0.004) \n0.1 (0.004-1.2) \n0.0004 (0.0-0.04) \n4.9 (1.0-14.0) \n0.0004 (0.0-0.003) \n0.0005 (0.0-0.003)  0.02* \n\n- \n- \n- \n- \n- \n- \n- \n- \n- \n\n6 \n\n\x0cEnterobacteriaceae \n\nVeillonella \nProteobacteria \n\n2.8 (0.4-13.6) \n18.7 (8.5-40.9) \n16.3 (6.8-39.3) \n0.001 (0.0004-0.006) \nVerrucomicrobiaceae  0.001 (0.0004-0.006) \n0.001 (0.0004-0.006) \nAkkermansia \n\n- \n- \n- \n0.02 \n0.02* \n0.02 \nResults are presented as median and inter quartile range in brackets. Comparisons were performed by Wilcoxon rank sum test. FDR was used to adjust p values \n\n2.8 (0.4-14.6) \n16.0 (6.5-34.0) \n15.0 (4.5-32.0) \n0.002 (0.0004-0.007) \n0.002 (0.0004-0.007) \n0.002 (0.0004-0.007) \n\n3.0 (0.3-12.4) \n14.5 (8.0-32.0) \n10.4 (4.6-21.4) \n0.001 (0.0-0.004) \n0.001 (0.0-0.004) \n0.001 (0.0-0.004) \n\n0.7 (0.1-4.3) \n19.6 (10.1-32.6) \n19.6 (8.7-32.6) \n0.01 (0.005-0.01) \n0.01 (0.005-0.01) \n0.01 (0.005-0.01) \n\n- \n0.09 \n0.01* \n0.11 \n0.11 \n0.11 \n\nVerrucomicrobia \n\nfor multiple testing, and p values <FDR p are indicated with ‘*’. P values <0.05 are indicated in boldface type. \n\n‡Comparison of Lactobacillaceae family was the primary hypothesis. \n \n\n \n\n7 \n\n\x0cTable S4. Median relative abundance of bacterial taxa at phylum, family and genus level in fecal microbiota at 3-4 months according \n\nto maternal asthma during pregnancy, restricted to Caucasian mothers and stratified by maternal pre-pregnancy weight. \n\nOverweight / Obese before pregnancy \nRestricted to Caucasian mothers \n\nNormal pre-pregnancy weight \nRestricted to Caucasian mothers \n\nAsthma \n(n=33) \n\nCrude \np \n\nNo Asthma \n(n=407) \n\nAsthma \n(n=36) \n\nCrude \np \n\n5.4 (1.8-22.2) \n0.02 (0.007-0.08) \n0.02 (0.005-0.07) \n4.9 (1.6-21.5) \n4.9 (1.6-21.5) \n32.6 (0.2-77.3) \n31.8 (0.09-68.4) \n31.8 (0.09-68.4) \n0.004 (0.002-0.8) \n10.9 (6.2-33.0) \n0.0004 (0.0-0.004) \n\n0.0004 (0.0-0.004) \n0.2 (0.04-1.0) \n0.01 (0.003-0.3) \n3.2 (0.2-9.2) \n0.0007 (0.0-0.05) \n0.0009 (0.0-0.009) \n0.4 (0.006-2.1) \n0.002 (0.0-0.06) \n2.6 (0.5-7.8) \n\n8 \n\n- \n- \n- \n- \n- \n- \n- \n- \n- \n- \n<0.04 \n\n<0.04 \n- \n- \n- \n- \n- \n- \n- \n- \n\n5.1 (1.0-16.3) \n0.02 (0.004-0.1) \n0.02 (0.003-0.09) \n4.9 (0.8-15.8) \n4.9 (0.8-15.8) \n12.4 (0.1-59.5) \n6.8 (0.07-55.3) \n6.8 (0.07-55.3) \n0.005 (0.002-0.1) \n24.3 (8.9-47.5) \n0.003 (0.0-0.06) \n\n0.003 (0.0-0.06) \n0.3 (0.03-2.8) \n0.02 (0.004-1.0) \n2.0 (0.04-10.7) \n0.001 (0.0-0.007) \n0.0004 (0.0-0.002) \n0.07 (0.003-1.3) \n0.0005 (0.0-0.06) \n4.2 (0.6-16.8) \n\n4.6 (1.0-14.1) \n0.03 (0.002-0.09) \n0.02 (0.002-0.09) \n4.3 (0.8-14.0) \n4.3 (0.8-14.0) \n26.1 (0.1-67.4) \n23.4 (0.09-56.5) \n23.4 (0.09-56.5) \n0.007 (0.003-0.5) \n21.3 (10.1-47.1) \n0.001 (0.0-0.009) \n\n0.001 (0.0-0.009) \n0.5 (0.009-3.3) \n0.01 (0.003-0.6) \n2.7 (0.1-13.6) \n0.001 (0.0002-0.1) \n0.0003 (0.0-0.002) \n0.02 (0.004-0.8) \n0.0004 (0.0-0.04) \n9.0 (1.1-18.2) \n\n- \n- \n- \n- \n- \n- \n- \n- \n- \n- \n0.10 \n\n0.10 \n- \n- \n- \n- \n- \n- \n- \n- \n\nNo Asthma \n(n=291) \n\n6.2 (1.8-15.5) \n0.03 (0.006-0.1) \n0.03 (0.005-0.1) \n5.2 (1.2-14.4) \n5.2 (1.2-14.4) \n23.1 (0.09-63.3) \n14.0 (0.07-55.8) \n14.0 (0.07-55.8) \n0.005 (0.002-0.3) \n21.1 (9.1-43.1) \n0.001 (0.0-0.04) \n\n0.001 (0.0-0.04) \n0.5 (0.06-2.3) \n0.02 (0.003-0.3) \n3.9 (0.5-10.0) \n0.002 (0.0-0.3) \n0.0006 (0.0-0.008) \n0.3 (0.009-2.1) \n0.003 (0.0-0.09) \n4.1 (0.8-15.8) \n\nacterial taxa \nActinobacteria \n\nActinomycetaceae \nActinomyces \nBifidobacteriaceae \nBifidobacterium \n\nBacteroidetes \n\nBacteroidaceae \nBacteroides \nPorphyromonadaceae \n\nFirmicutes \n\n‡Lactobacillaceae \n‡Lactobacillus \nClostridiaceae \nClostridium \nLachnospiraceae \nBlautia \nDorea \nRuminococcaceae \nRuminococcus \nVeillonellaceae \n\n        B\n\n \n\n\x0cDialister \nMegasphaera \nVeillonella \nProteobacteria \n\nEnterobacteriaceae \n\n0.0005 (0.0-0.004) \n0.001 (0.0-0.007) \n2.4 (0.3-13.2) \n16.4 (6.5-38.9) \n14.4 (4.7-36.7) \n\n0.0 (0.0-0.003) \n0.0004 (0.0-0.001) \n2.6 (0.2-7.7) \n16.6 (5.5-24.8) \n14.8 (1.9-21.8) \n\n- \n0.0005 (0.0-0.004) \n0.009*  0.001 (0.0-0.005) \n- \n- \n- \n\n3.2 (0.4-15.1) \n19.1 (9.3-39.5) \n17.6 (7.2-37.2) \n\n0.0007 (0.0-0.003) \n0.0009 (0.0-0.004) \n3.6 (0.3-14.0) \n14.1 (9.9-33.3) \n10.4 (6.5-31.8) \n\nVerrucomicrobia \n\n0.002 (0.0006-0.007) \n\n0.003 (0.0009-0.01) \n\n- \n\n0.002 (0.0004-0.006)  0.002 (0.0-0.004) \n\n- \n- \n- \n- \n- \n\n- \n\nVerrucomicrobiaceae \nAkkermansia \n\n- \n- \nResults are presented as median and inter quartile range in brackets. Comparisons were performed by Wilcoxon rank sum test. FDR was used to adjust p values \n\n0.002 (0.0004-0.006)  0.002 (0.0-0.004) \n0.002 (0.0004-0.006)  0.002 (0.0-0.004) \n\n0.002 (0.0006-0.007) \n0.002 (0.0006-0.007) \n\n0.003 (0.0009-0.01) \n0.003 (0.0009-0.01) \n\n- \n- \n\nfor multiple testing, and p values <FDR p are indicated with ‘*’. P values <0.05 are indicated in boldface type. \n\n‡Comparison of Lactobacillaceae family was the primary hypothesis. \n\n \n\n \n\n9 \n\n\x0c']